Atrás
29
Rango del Día
$493.24
$502.73
Rango de 52 Semanas
$465.59
$601.77
Volumen
2,277,345
Promedio 50D / 200D
$527.07
/
$556.85
Cierre Anterior
$500.38
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Financial Services (854 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 29.8 | 10.3 |
| P/B | 57.6 | 1.1 |
| ROE % | 210.5 | 11.7 |
| Net Margin % | 45.7 | 16.8 |
| Rev Growth 5Y % | 14.8 | 11.6 |
| D/E | 2.5 | 0.5 |
Precio Objetivo de Analistas
Hold
$667.33
+33.8%
Low: $610.00
High: $739.00
P/E Futuro
25.6
EPS Futuro
$19.58
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
37 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$34.13
$33.40 – $34.87
|
57 B | 4 |
| FY2029 |
$29.70
$29.07 – $30.34
|
52 B | 4 |
| FY2028 |
$26.33
$25.24 – $27.08
|
47 B | 10 |
Insider Trading Activity
Buy ratio (90d)
50.0%
18 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 |
ABRAMS CAPITAL MANAGEMENT, L.P.
|
buy | 1,758,794 | $7.00 | $12,311,558 |
| Jan 13, 2026 |
Flagship Pioneering, LLC
|
grant | 4,470,936 | $6.71 | — |
| Jan 5, 2026 |
North Run Strategic Opportunities Fund I, LP
|
buy | 3,499,289 | $2.58 | $9,028,166 |
| Jan 5, 2026 |
North Run Strategic Opportunities Fund I, LP
|
sell | 4,269,610 | $11.72 | — |
| Jan 1, 2026 |
SUMMIT PARTNERS L P
|
buy | 354,189 | — | — |
| Jan 1, 2026 |
SUMMIT PARTNERS L P
|
other | 354,189 | — | — |
| Jan 1, 2026 |
SUMMIT PARTNERS L P
|
sell | 354,189 | — | — |
| Dec 31, 2025 |
North Run Strategic Opportunities Fund I, LP
|
sell | 1,860,465 | $2.15 | $4,000,000 |
| Nov 7, 2025 |
ADVENT INTERNATIONAL, L.P.
|
sell | 37,342,526 | $7.76 | $289,856,421 |
| Aug 26, 2025 |
THOMAS H. LEE ADVISORS, LLC
|
sell | 22,669,211 | — | — |
| Aug 21, 2025 |
DC VGA LLC
|
sell | 1,388,888 | $14.41 | $20,013,876 |
| Aug 7, 2025 |
ADVENT INTERNATIONAL, L.P.
|
sell | 30,000,000 | $9.87 | $296,145,000 |
| May 20, 2025 |
ADVENT INTERNATIONAL, L.P.
|
sell | 30,000,000 | $9.08 | $272,400,000 |
| May 19, 2025 |
Berkshire Partners LLC
|
sell | 17,290,465 | $12.23 | — |
| May 19, 2025 |
Berkshire Partners LLC
|
buy | 7,290,465 | — | — |
| May 16, 2025 |
ABRAMS CAPITAL MANAGEMENT, L.P.
|
sell | 703,691 | $80.91 | $56,934,020 |
| May 15, 2025 |
ABRAMS CAPITAL MANAGEMENT, L.P.
|
sell | 4,673,986 | $80.91 | $378,161,457 |
| May 13, 2025 |
MPM BioVentures 2014, L.P.
|
sell | 630,191 | $8.06 | $5,079,339 |
Puntos Clave
Revenue grew 14.79% annually over 5 years — strong growth
Earnings grew 16.27% over the past year
ROE of 210.49% indicates high profitability
Net margin of 45.65% shows strong profitability
Debt/Equity of 2.46 — high leverage
Generating 16.91B in free cash flow
Crecimiento
Revenue Growth (5Y)
14.79%
Revenue (1Y)16.42%
Earnings (1Y)16.27%
FCF Growth (3Y)20.70%
Calidad
Return on Equity
210.49%
ROIC54.42%
Net Margin45.65%
Op. Margin59.17%
Seguridad
Debt / Equity
2.46
Current Ratio1.03
Interest Coverage26.87
Valoración
P/E Ratio
29.75
P/B Ratio57.55
EV/EBITDA23.36
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.42% | Revenue Growth (3Y) | 14.30% |
| Earnings Growth (1Y) | 16.27% | Earnings Growth (3Y) | 15.63% |
| Revenue Growth (5Y) | 14.79% | Earnings Growth (5Y) | 14.57% |
| Profitability | |||
| Revenue (TTM) | 32.79B | Net Income (TTM) | 14.97B |
| ROE | 210.49% | ROA | 27.64% |
| Gross Margin | 83.43% | Operating Margin | 59.17% |
| Net Margin | 45.65% | Free Cash Flow (TTM) | 16.91B |
| ROIC | 54.42% | FCF Growth (3Y) | 20.70% |
| Safety | |||
| Debt / Equity | 2.46 | Current Ratio | 1.03 |
| Interest Coverage | 26.87 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 29.75 | P/B Ratio | 57.55 |
| P/S Ratio | 13.58 | PEG Ratio | 1.81 |
| EV/EBITDA | 23.36 | Dividend Yield | 0.01% |
| Market Cap | 445.26B | Enterprise Value | 453.14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 32.79B | 28.17B | 25.10B | 22.24B | 18.88B |
| Net Income | 14.97B | 12.87B | 11.20B | 9.93B | 8.69B |
| EPS (Diluted) | 16.52 | 13.89 | 11.83 | 10.23 | 8.76 |
| Gross Profit | 27.36B | 21.49B | 19.08B | 16.97B | 14.40B |
| Operating Income | 19.40B | 15.58B | 14.01B | 12.26B | 10.08B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 54.16B | 48.08B | 42.45B | 38.72B | 37.67B |
| Total Liabilities | 46.41B | 41.57B | 35.45B | 32.35B | 30.26B |
| Shareholders' Equity | 7.74B | 6.49B | 6.93B | 6.30B | 7.31B |
| Total Debt | 19.00B | 18.23B | 15.68B | 14.02B | 13.90B |
| Cash & Equivalents | 11.13B | 8.44B | 8.59B | 7.01B | 7.42B |
| Current Assets | 23.56B | 19.72B | 18.96B | 16.61B | 16.95B |
| Current Liabilities | 22.76B | 19.22B | 16.26B | 14.17B | 13.16B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#139 of 157
Actividad Reciente
Entró
Growth Investing (Philip Fisher)
Mar 24, 2026